JP6698556B2 - 抗微生物性ペプチド、その医薬組成物および使用方法 - Google Patents

抗微生物性ペプチド、その医薬組成物および使用方法 Download PDF

Info

Publication number
JP6698556B2
JP6698556B2 JP2016572236A JP2016572236A JP6698556B2 JP 6698556 B2 JP6698556 B2 JP 6698556B2 JP 2016572236 A JP2016572236 A JP 2016572236A JP 2016572236 A JP2016572236 A JP 2016572236A JP 6698556 B2 JP6698556 B2 JP 6698556B2
Authority
JP
Japan
Prior art keywords
peptide
xaa
composition
ile
product
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2016572236A
Other languages
English (en)
Japanese (ja)
Other versions
JP2017530088A5 (enExample
JP2017530088A (ja
Inventor
ジエ チェン
ジエ チェン
アン マリー クノルホフ
アン マリー クノルホフ
エリック ウェイン ブラウン
エリック ウェイン ブラウン
ティモシー レイ クローリー
ティモシー レイ クローリー
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
United States Department of Health and Human Services
Original Assignee
United States Department of Health and Human Services
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by United States Department of Health and Human Services filed Critical United States Department of Health and Human Services
Publication of JP2017530088A publication Critical patent/JP2017530088A/ja
Publication of JP2017530088A5 publication Critical patent/JP2017530088A5/ja
Application granted granted Critical
Publication of JP6698556B2 publication Critical patent/JP6698556B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50—Cyclic peptides containing at least one abnormal peptide link
    • C07K7/54—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
    • C07K7/56—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation not occurring through 2,4-diamino-butanoic acid
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N37/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids
    • A01N37/44—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids containing at least one carboxylic group or a thio analogue, or a derivative thereof, and a nitrogen atom attached to the same carbon skeleton by a single or double bond, this nitrogen atom not being a member of a derivative or of a thio analogue of a carboxylic group, e.g. amino-carboxylic acids
    • A01N37/46—N-acyl derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10—Peptides having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/542—Carboxylic acids, e.g. a fatty acid or an amino acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K19/00—Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64—Cyclic peptides containing only normal peptide links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Dentistry (AREA)
  • Plant Pathology (AREA)
  • Agronomy & Crop Science (AREA)
  • Pest Control & Pesticides (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Peptides Or Proteins (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
  • Materials For Medical Uses (AREA)
  • Cosmetics (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Fodder In General (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
JP2016572236A 2014-06-09 2015-06-09 抗微生物性ペプチド、その医薬組成物および使用方法 Active JP6698556B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201462009467P 2014-06-09 2014-06-09
US62/009,467 2014-06-09
PCT/US2015/034859 WO2015191551A1 (en) 2014-06-09 2015-06-09 Antimicrobial peptides, pharmaceutical compositions, and methods of use thereof

Publications (3)

Publication Number Publication Date
JP2017530088A JP2017530088A (ja) 2017-10-12
JP2017530088A5 JP2017530088A5 (enExample) 2018-07-19
JP6698556B2 true JP6698556B2 (ja) 2020-05-27

Family

ID=53443015

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016572236A Active JP6698556B2 (ja) 2014-06-09 2015-06-09 抗微生物性ペプチド、その医薬組成物および使用方法

Country Status (6)

Country Link
US (2) US10118948B2 (enExample)
EP (1) EP3152224B1 (enExample)
JP (1) JP6698556B2 (enExample)
AU (1) AU2015274889B2 (enExample)
CA (1) CA2951386C (enExample)
WO (1) WO2015191551A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2015274889B2 (en) 2014-06-09 2019-01-17 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Antimicrobial peptides, pharmaceutical compositions, and methods of use thereof
WO2019028463A1 (en) * 2017-08-04 2019-02-07 Bioventures, Llc LINEAR LIPOPEPTIDE PAENIPEPTINS AND METHODS OF USE
EP4192847A1 (en) * 2020-08-10 2023-06-14 Università Cattolica del Sacro Cuore New antimicrobial peptides

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5762928A (en) 1997-06-05 1998-06-09 Campbell Soup Company Biocontrol agent for green mold disease of mushrooms
WO2006099306A2 (en) 2005-03-10 2006-09-21 Custom Medical Applications, Inc. Catheter connection hub
UA15147U (en) 2005-12-20 2006-06-15 Instex And Clinical Veterinary ôLACTOSPORö, A COMPLEX AGENT FOR PROPHYLAXIS AND TREATMENT OF CALVES GASTROINTESTINAL DISEASES
ATE505197T1 (de) 2006-09-28 2011-04-15 Univ Ohio State Res Found Antibiotische und antimikrobielle wirkstoffe sowie verfahren zu ihrer verwendung
MX356959B (es) 2011-05-20 2018-06-21 The Us Secretary Department Of Health & Human Services Cepa paenibacillus alvei ts-15 y su uso en el control de organismos patogenicos.
WO2013086003A1 (en) * 2011-12-05 2013-06-13 The Ohio State University Antimicrobial agent, bacterial strain, biosynthesis, and methods of use
AU2015274889B2 (en) 2014-06-09 2019-01-17 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Antimicrobial peptides, pharmaceutical compositions, and methods of use thereof

Also Published As

Publication number Publication date
US20170145057A1 (en) 2017-05-25
CA2951386A1 (en) 2015-12-17
CA2951386C (en) 2020-10-27
AU2015274889B2 (en) 2019-01-17
EP3152224A1 (en) 2017-04-12
US10118948B2 (en) 2018-11-06
US20190016757A1 (en) 2019-01-17
US10906940B2 (en) 2021-02-02
WO2015191551A1 (en) 2015-12-17
AU2015274889A1 (en) 2017-01-05
JP2017530088A (ja) 2017-10-12
EP3152224B1 (en) 2018-07-25

Similar Documents

Publication Publication Date Title
KR102419616B1 (ko) 항균 요법
JP6683601B2 (ja) 抗菌性ペプチド
US9017692B2 (en) Antimicrobial agent, bacterial strain, biosynthesis, and methods of use
WO2019018499A2 (en) ANTIMICROBIAL PEPTIDES STABILIZED FOR THE TREATMENT OF ANTIBIOTIC-RESISTANT BACTERIAL INFECTIONS
US11548916B2 (en) Anti-infective compound
JPH09509175A (ja) 広域スペクトル抗菌化合物と使用方法
DK3087092T3 (en) ANTIMICROBIAL PEPTID AND APPLICATIONS THEREOF
KR20070107748A (ko) 항미생물성 헥사펩티드
US10906940B2 (en) Antimicrobial peptides, pharmaceutical compositions, and methods of use thereof
Baldassarre et al. Discovery of novel RIP derivatives by alanine scanning for the treatment of S. aureus infections
EP4423112A1 (en) Antibacterial peptide
US20050171335A1 (en) Novel antimicrobial peptide and use thereof
KR102250981B1 (ko) 항균 활성, 용혈 안정성 및 혈청 내 안정성이 증진된 항균 펩타이드 유도체
KR101865782B1 (ko) 바실러스 아밀로리퀴파시엔스 k14로부터 단리된 신규 항균 펩타이드 및 그의 용도
EP3212661A1 (en) Cyclic antimicrobial pseudopeptides and uses thereof
JP4154218B2 (ja) 新規抗菌性ポリペプチドとその利用
EP4284812A1 (en) Novel selective antimicrobial fusion peptides
CN104478993A (zh) 一种非蛋白氨基酸抗菌肽及其应用

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20170206

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20180607

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20180607

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20190521

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20190809

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20190903

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20191112

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20200407

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20200428

R150 Certificate of patent or registration of utility model

Ref document number: 6698556

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250